Gapping up
In reaction to earnings/guidance:
- MTN +3.7%, NAPA +2.7%, JEF +1.6%
Other news:
- AXSM +4.3% (discloses plans to resubmit AXS-07 NDA based on successful FDA type a meeting)
- IVVD +4.1% (files for $400 mln mixed securities shelf offering)
- DCFC +3.1% (to supply fast chargers for Australia's longest EV highway)
- MNTS +2% (launches 3-yr $50 mln at-the-market equity program)
- MOR +2% (announces data from the ongoing L-MIND study)
- ATRA +1.6% (to receive additional milestone payment)
- CCCC +1.2% (received a Study May Proceed Letter from the FDA to begin a Phase 1/2 trial for CFT1946 a treatment of BRAF-V600 mutant solid tumors)
- SVC +1.1% (to sell 16 hotels for $137.3 mln)
- ATCO +0.9% (confirms receipt of revised proposal from Poseidon to acquire ATCO for $15.50/sh)
Analyst comments:
- FSLR +2.1% (upgraded to Outperform from In-line at Evercore ISI)